Douglas H. Sweet

4.8k citations
63 papers · 3.9k indexed · h-index 34

Douglas H. Sweet

63 papers receiving 3.8k citations

Peers

Douglas H. Sweet
Comparison fields: 5 of 112
  • Clinical Biochemistry 537
  • Oncology 2.1k
  • Pharmacology 594
  • Biochemistry 449
  • Pediatrics, Perinatology and Child Health 1.1k
Replace Gerald Salen with:
Gerald Salen United States
Joseph K. Ritter United States
Munehiro Kitada Japan
Akihiro Tojo Japan
Ulf Diczfalusy Sweden
Toshifumi Aoyama Japan
Norman B. Javitt United States
Bhagwat Prasad United States
Fanfan Zhou Australia
Ingemar Björkhem Sweden
Douglas H. Sweet relative to Gerald Salen United States Gerald Salen's profile →
Citations per field
00.5×3.4×
Gerald Salen · 1×
Citations per year

Countries citing papers authored by Douglas H. Sweet

Since Specialization
Citations

This map shows the geographic impact of Douglas H. Sweet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas H. Sweet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas H. Sweet more than expected).

Fields of papers citing papers by Douglas H. Sweet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas H. Sweet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas H. Sweet. The network helps show where Douglas H. Sweet may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Douglas H. Sweet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Douglas H. Sweet Line = papers co-authored together Douglas H. Sweet links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201758
2 2014132
3 20149
4 201422
5 201332
6 201225
7 201229
8 201155
9 200887
10 2008182
11 200840
12 200763
13 200767
14 200651
15 200636
16 200494
17 200339
18 200160
19 199966
20 199960

About Douglas H. Sweet

Douglas H. Sweet is a scholar working on Oncology, Clinical Biochemistry and Biochemistry, having authored 63 papers that have together received 3.9k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (42 papers), Pharmacological Effects and Toxicity Studies (12 papers), Metabolism and Genetic Disorders (10 papers), Neonatal Health and Biochemistry (9 papers), Amino Acid Enzymes and Metabolism (8 papers), Ion Transport and Channel Regulation (8 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Pharmacological Effects of Natural Compounds (5 papers). The work is most often cited by research in Clinical Biochemistry (537 citations), Oncology (2.1k citations) and Pharmacology (594 citations). Douglas H. Sweet has collaborated with scholars based in United States, Germany and Taiwan. Frequent co-authors include John B. Pritchard, Li Wang, David S. Miller, Adam L. VanWert, Natascha A. Wolff, Sanjay K. Nigám, Geri L. Youngblood, Michael R. Gionfriddo, Ramsey Walden and Kevin T. Bush. Their work appears in journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Cell Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026